A wet AMD biosimilar approval leads this week’s recap, plus Medicare pay updates and tips to avoid burnout and losing patients.
|Articles|April 14, 2020
Video: Contact lens wear still safe amid COVID-19
Advertisement
Edward S. Bennett, OD, MSEd, FAAO, explains how contact lens wear continues to be safe and offers suggestions to ODs to help their contact lens-wearing patients now during the COVID-19 pandemic as well as after they open their practice doors again to routine care.
Advertisement
Related to this article
ODs face a $32.63 Medicare conversion factor in 2027, plus 80% payment for the lower-cost service when an E/M visit and 0-day procedure share a date.
Christopher Browning, OD, and Nicholas Garn, OD, now offer cataract surgery and refractive lens exchange in their own practices.
According to Raphael Rostenne, CTO of EyeCarePro, "anything that takes time" has the potential to frustrate patients, especially before they're in a practitioner's chair.
Kansas, Tennessee, and Vermont expanded optometric scope in 2026, while vision plan reform and a proposed Medicare fee schedule cut affect practice management.
This week’s top stories include pipeline updates in dry eye, retinitis pigmentosa, contact lens hygiene, and more.
Raphael Rostenne discusses what a good phone call looks like and contributes to successful patient interactions with host Diana Canto-Sims, OD.
This week's top stories include breaking FDA approvals, insights on AI-assisted front desk management, and more.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Indiana optometrists open state’s first OD-owned surgical suites
2
2027 Medicare fee schedule trims same-day E/M, 0-day procedure pay
3
Takeaways from this week in optometry: November 2-6
4
FDA approves ranibizumab biosimilar Lucamzi for wet AMD
5